Badrilla Ltd, founded in 2003, is an established life science company providing high quality products for the molecular cardiovascular researcher located within major pharmaceutical, biotech, and academic establishments worldwide... Read More
Professor Colyer established Badrilla in 2003, combining substantive entrepeneurial experience with a deep understanding of the cardiovascular research field. The company has grown organically, reinvesting revenues into... Read More
A functional ubiquitin-proteasome system (UPS) is critical for normal protein turnover and its role is to remove damaged or misfolded proteins via proteolysis of polyubiquitinated species. The accumulation of polyubiquitinated proteins is a hallmark of proteasome dysfunction and is the most commonly used measure for assessing UPS function in human DCM and heart failure. A consistent observation is that levels of polyubiquitinated proteins are increased in DCM/failing hearts compared with control hearts (find out more about this here). This is typically measured by semi-quantitative Western blot analysis using ubiquitin antibodies.
Key findings to date:
Further reading: The ubiquitin proteasome system in human cardiomyopathies and heart failure. Am J Physiol Heart Circ Physiol. 2013 May 15; 304(10): H1283–H1293. [PubMed]
Which tools do I need? Badrilla is pleased to offer new panel of reagents to facilitate the study of the ubiquitin-proteasome system in cardiac samples.
There are no products matching the selection.
You have no items to compare.
.
DISCLAIMER: Products for research use only (RUO) and are not intended for diagnostic or therapeutic use.